Phase 2 Ovarian Cancer Trial, Not Yet Recruiting NCT07295132 Sponsor: Asan Medical Center Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 2 Ovarian Cancer Trial, Not Yet Recruiting

NCT07295132
Not Yet Recruiting Phase 2

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have had their first recurrence of a specific type of ovarian, fallopian tube, or primary peritoneal cancer (invasive epithelial type), regardless of what stage it was when first diagnosed.
  • People whose cancer did not come back until at least 6 months after finishing their last platinum-based chemotherapy treatment.
  • People whose cancer showed a response to chemotherapy given before surgery after the recurrence — this includes the cancer shrinking, disappearing, or staying stable according to specific measurement standards (confirm with trial site).
  • Women aged 19 years or older.
  • People whose cancer is judged by an experienced surgeon to be fully removable through surgery.
  • People who have signed a written consent form and agreed to allow their data to be used and processed for the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose cancer has not come back (no recurrence).
  • People whose tumor is not of the epithelial type, or whose tumor is classified as a borderline tumor.
  • People who are experiencing their second, third, or later recurrence of cancer.
  • People who have had another type of cancer that required major surgery or other treatments likely to interfere with the treatment of the recurring ovarian cancer or significantly affect their outlook.
  • People whose cancer did not respond to platinum-based chemotherapy — meaning the cancer kept growing during treatment or came back within 6 months of finishing the first platinum-based treatment.
  • People for whom only palliative (comfort-focused, non-curative) surgery is planned.
  • People whose scans show signs of cancer spread that cannot be fully removed by surgery.
  • People with other health conditions that would make surgery or chemotherapy unsafe (for example, very poor general health, serious infection, conditions that may cause severe bleeding, or severe kidney disease).
  • People with a medical history that would make surgery carry an unusually high risk before or after the operation.
  • People currently taking medications that create significant surgical risks, such as blood thinners or certain cancer drugs that increase bleeding risk.
  • People for whom stored tumor tissue samples are not available for testing.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Principal Investigator: Dae-Yeon Kim, Asam Medical Center

Phone: +82-2-30103748

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 2
Registry
ClinicalTrials.gov
Start date
15 December 2025
Est. completion
15 November 2029

Primary endpoints

Progression-Free Survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov